These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 35817497)

  • 1. Asserting public health interest in acting on commercial determinants of health in sub-Saharan Africa: insights from a discourse analysis.
    Loewenson R; Godt S; Chanda-Kapata P
    BMJ Glob Health; 2022 Jul; 7(7):. PubMed ID: 35817497
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Using Regulatory Stances to See All the Commercial Determinants of Health.
    Liber AC
    Milbank Q; 2022 Sep; 100(3):918-961. PubMed ID: 35579322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Power and Other Commercial Determinants of Health: An Empirical Study of the Australian Food, Alcohol, and Gambling Industries.
    de Lacy-Vawdon C; Vandenberg B; Livingstone C
    Int J Health Policy Manag; 2023; 12():7723. PubMed ID: 37579379
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conceptualising commercial entities in public health: beyond unhealthy commodities and transnational corporations.
    Lacy-Nichols J; Nandi S; Mialon M; McCambridge J; Lee K; Jones A; Gilmore AB; Galea S; de Lacy-Vawdon C; de Carvalho CMP; Baum F; Moodie R
    Lancet; 2023 Apr; 401(10383):1214-1228. PubMed ID: 36966783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Healthy people and healthy profits? Elaborating a conceptual framework for governing the commercial determinants of non-communicable diseases and identifying options for reducing risk exposure.
    Buse K; Tanaka S; Hawkes S
    Global Health; 2017 Jun; 13(1):34. PubMed ID: 28619031
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Australia in 2030: what is our path to health for all?
    Backholer K; Baum F; Finlay SM; Friel S; Giles-Corti B; Jones A; Patrick R; Shill J; Townsend B; Armstrong F; Baker P; Bowen K; Browne J; Büsst C; Butt A; Canuto K; Canuto K; Capon A; Corben K; Daube M; Goldfeld S; Grenfell R; Gunn L; Harris P; Horton K; Keane L; Lacy-Nichols J; Lo SN; Lovett RW; Lowe M; Martin JE; Neal N; Peeters A; Pettman T; Thoms A; Thow AMT; Timperio A; Williams C; Wright A; Zapata-Diomedi B; Demaio S
    Med J Aust; 2021 May; 214 Suppl 8():S5-S40. PubMed ID: 33934362
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bringing the commercial determinants of health out of the shadows: a review of how the commercial determinants are represented in conceptual frameworks.
    Maani N; Collin J; Friel S; Gilmore AB; McCambridge J; Robertson L; Petticrew MP
    Eur J Public Health; 2020 Aug; 30(4):660-664. PubMed ID: 31953933
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Commercial determinants of health: an ethical exploration.
    Ndebele P; Shaikh H; Paichadze N; Bari I; Michaels D; Santos Burgoa C; Hyder AA
    Int J Public Health; 2020 Sep; 65(7):1123-1132. PubMed ID: 32840631
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Defining and conceptualising the commercial determinants of health.
    Gilmore AB; Fabbri A; Baum F; Bertscher A; Bondy K; Chang HJ; Demaio S; Erzse A; Freudenberg N; Friel S; Hofman KJ; Johns P; Abdool Karim S; Lacy-Nichols J; de Carvalho CMP; Marten R; McKee M; Petticrew M; Robertson L; Tangcharoensathien V; Thow AM
    Lancet; 2023 Apr; 401(10383):1194-1213. PubMed ID: 36966782
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Constructing public-private partnerships to undermine the public interest: critical discourse analysis of Working Together published by the International Alliance for Responsible Drinking.
    Madden M; Bartlett A; McCambridge J
    Global Health; 2023 Dec; 19(1):103. PubMed ID: 38104100
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Defining Priorities for Action and Research on the Commercial Determinants of Health: A Conceptual Review.
    Freudenberg N; Lee K; Buse K; Collin J; Crosbie E; Friel S; Klein DE; Lima JM; Marten R; Mialon M; Zenone M
    Am J Public Health; 2021 Dec; 111(12):2202-2211. PubMed ID: 34878875
    [TBL] [Abstract][Full Text] [Related]  

  • 12. How do actors with asymmetrical power assert authority in policy agenda-setting? A study of authority claims by health actors in trade policy.
    Townsend B; Schram A; Labonté R; Baum F; Friel S
    Soc Sci Med; 2019 Sep; 236():112430. PubMed ID: 31351362
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Commercial determinants of health: future directions.
    Friel S; Collin J; Daube M; Depoux A; Freudenberg N; Gilmore AB; Johns P; Laar A; Marten R; McKee M; Mialon M
    Lancet; 2023 Apr; 401(10383):1229-1240. PubMed ID: 36966784
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The informal governance of public-private partnerships in UK obesity policy: Collaborating on calorie reduction or reducing effectiveness?
    Ralston R
    Soc Sci Med; 2021 Nov; 289():114451. PubMed ID: 34673355
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fifty shades of partnerships: a governance typology for public private engagement in the nutrition sector.
    Patay D; Ralston R; Palu A; Jones A; Webster J; Buse K
    Global Health; 2023 Feb; 19(1):11. PubMed ID: 36804923
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is the commercial determinants conversation confined to the health sciences? Potentially, and that's a problem.
    Hagenaars LL; Maani N; Schmidt LA
    Global Health; 2024 Jan; 20(1):3. PubMed ID: 38167207
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Implementation of medicines pricing policies in sub-Saharan Africa: systematic review.
    Koduah A; Baatiema L; de Chavez AC; Danso-Appiah A; Kretchy IA; Agyepong IA; King N; Ensor T; Mirzoev T
    Syst Rev; 2022 Dec; 11(1):257. PubMed ID: 36457058
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A framework of NGO inside and outside strategies in the commercial determinants of health: findings from a narrative review.
    Townsend B; Johnson TD; Ralston R; Cullerton K; Martin J; Collin J; Baum F; Arnanz L; Holmes R; Friel S
    Global Health; 2023 Oct; 19(1):74. PubMed ID: 37817196
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Access to Veterinary Drugs in Sub-Saharan Africa: Roadblocks and Current Solutions.
    Jaime G; Hobeika A; Figuié M
    Front Vet Sci; 2021; 8():558973. PubMed ID: 35356415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mandela calls for greater commitment and leadership in fighting AIDS. The World Economic Forum -- Policy and business in a world of HIV / AIDS.
    Macinnis R
    AIDSlink; 1997; (43):1, 3. PubMed ID: 12321752
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.